Dr. Huang Yadong, Chief Scienε₩ tist of Tyran Technology Group ,≤←Ω led the team to succe®&×ssfully use genetic e✔α÷ngineering methods to produce recom←♠&binant antimicrobialΩγ≠ peptides and apply them to ♠←Ω green farming and s₽∑πkin anti-infection, adΩ₩vocating a new concept of repair≈"÷ and beauty.
Dr. Huang Yadong, Chief Scie∞"♣ntist of TyranTechnology Group , par 'γticipated in and successfully devel÷€oped a new genetically engin₩←eered class I drug, ×§rh-aFGF, and applied it to wound §δ∞£repair.
The combined application of animal <₹collagen and growth factor₹∞✘ has developed the first medical device≠" product with a combinatio₹"n of drugs and devices i®÷n China.
Guangzhou Jyran Biotechnology C✔✘o., Ltd., the first enterprise of Tyr<anTechnology Group , was forma♠≤lly established, and ♦γthe first fully automatic freeze-drαπ• ying production line with a produ€♦£ction capacity of more than 1≠♠00 million pieces was estaγσ'πblished in China.
Develop a new biotransdermal tech♣↕÷™nology based on liposome encapsulati"on and nano-emulsion, and estδ↑ablish the e-commerce →channel freeze-dried repair braΩεΩ"nd [Liprestide].
Founded the [SMR] medical skin ca☆☆re brand, using the combi>Ωnation of "machiner•≠≤y + makeup" products, focusing on±α the repair of proble∑ →matic skin.
Founded Tyran (Guangzhou) Biotγσ•©echnology Co., Ltd.], entered th≈§βe field of biomateri≥®als and medical devicλ✘ε×es, and passed the certification of &λ13485.
Participated in the formulation of the "≠δonly group standard for freeze-drie₩¥±d skin care products in ™♠λ♥China, and promoted the inc<lusion of freeze-dried ∑φ₩βskin care products in the new natiγ★onal cosmetics classification cataσ♠log.
[Guangdong TyranTechnology Gr♣↕oup Co., Ltd.] was fo↓≈®δrmally established, and plans to buiσ↔πld an advanced manufacturing indust♦&rial park covering an area of 25 acr'<es and a constructio↓±αn area of about 70,000 $σ≤square meters.
Founded Changsha Jyran Biotechnolo< ★gy Co., Ltd. And obtained t♥☆he production license, and ♠δsuccessfully passed the ISO13485 intern™ ∑ational quality management system cert ≠ification. In addition, th ∑≤e company has been approved to hold ♠∑11 Class II medical ♣λ♠device production registration certif>©®δicates. The company is ☆© ↔committed to building a modern pr§oduction base for medical dev∞✘♣ices.
It has been funded by the &q≤←uot;Guangzhou Specialized a♦nd Special New Private Enterprise Su₩λpport Program Cultivation Enterprise&®βquot;, "Guangdong₹¶ Province Innovative Small§<λ and Medium-sized Enterprises&₩✘quot;, "Guangdong Province Specialβ↓↕∏ized and Special New S₩↓π mall and Medium-sized Enterprises&qu✘£₩ot;, "Guangdong Proviσδnce Medical Beauty Materials and Fu★'∑₹nctional Skin Care Products Eng'γ ineering Technology Research Ce ∏" nter", and "Guangdo∏ πng Province Key Area R&D Progr'&↑am Project".
Recombinant type III humanized collagσ∏en has been registered™σ in the national NMPA for the m ∑aster file of medical devic★→e raw materials, and more than 10§ Class 1 medical device registration ≤♠♠ certificates have been approve∞γ±'d, and a multi-center c£&πlinical study of Class II medical devic ↕¥es has been carried out.